Cirrhosis News and Research

Latest Cirrhosis News and Research

MRI contrast agent enables early detection of liver disease

Researchers have developed a new MRI contrast dye that enables more accurate and safer detection of early-stage liver disease than currently approved agents.

30 Oct 2019

Cleveland Clinic successfully performs first laparoscopic living donor liver transplantation

Cleveland Clinic has successfully performed the Midwest's first purely laparoscopic living donor surgery for liver transplantation in an adult recipient.

30 Oct 2019

IU researcher receives NIH grant to perform clinical trial on cirrhosis

An Indiana University School of Medicine researcher has been awarded a five-year, $1.8 million grant from the National Institutes of Health for a clinical trial, aimed at providing new avenues to improve liver function for patients with alcoholic cirrhosis.

30 Oct 2019

First effective noninvasive method for diagnosing early-stage liver diseases

A safer and more sensitive contrast dye for MRI tests developed by a team led by Georgia State University researchers may provide the first effective, noninvasive method for detecting and diagnosing early-stage liver diseases, including liver fibrosis.

29 Oct 2019

New diagnostic technique enables grading of tumor consistency using MRI

Researchers from Charité - Universitätsmedizin Berlin have developed a new diagnostic technique which enables the grading of tumor consistency using magnetic resonance imaging (MRI). The researchers used an imaging technique known as tomoelastography to visualize the mechanical properties of liver tumors.

28 Oct 2019

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

When a long, black bus bearing the logo of drugmaker AbbVie rolls through Washington state next year, it will promote a new effort to eradicate hepatitis C infections.

25 Oct 2019

Study shows why fatty liver disease contributes to increase in liver cancer

Fatty liver disease is contributing to an increase in liver cancer and basic scientists at The University of Texas Health Science at Houston have new insight as to why.

16 Oct 2019

Researchers track cell family trees to discover their role in tissue scarring and liver disease

Researchers have discovered that a key cell type involved in liver injury and cancer consists of two cellular families with different origins and functions.

15 Oct 2019

Researchers identify new targets to treat fibrotic diseases

When it comes to repairing injured tissue, specialized cells in the body known as fibroblasts are called into action. Fibroblasts give rise to healing cells called myofibroblasts, which generally is good in the short term - but bad when myofibroblast activation gets out of hand.

4 Oct 2019

Better methods needed to identify people at risk for liver disease

While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most need of care.

27 Sep 2019

TUM researchers identify complex interactions between bacteria and parasites

A team at the Technical University of Munich has completed the first study of the effects of a simultaneous infection with blood flukes (schistosomes) and the bacterium Helicobacter pylori - a fairly common occurrence in some parts of the world.

19 Sep 2019

Abnormal gut bacteria linked to poor cognitive performance in vets with PTSD and cirrhosis

A study involving military veterans with PTSD and cirrhosis of the liver points to an abnormal mix of bacteria in the intestines as a possible driver of poor cognitive performance--and as a potential target for therapy.

13 Sep 2019

Breakthrough study shows transplanting Hepatitis C-infected kidneys is safe

Hepatitis C is a viral infection that affects the liver and is usually acquired from infected blood. Formerly called non-A, non-B hepatitis, this infection causes inflammation of the liver, sometimes causing serious liver damage.

2 Sep 2019

'Lab on a chip' technology may help find new treatments for NAFLD

Non-alcoholic fatty liver disease--the accumulation of liver fat in people who drink little or no alcohol--is increasingly common around the world, and in the United States, it affects between 30 and 40 percent of adults.

29 Aug 2019

Researchers discover how fatty liver disease develops in lean people

Researchers from The Westmead Institute for Medical Research (WIMR) have discovered how fatty liver disease develops in lean people, aiding the development of potential treatments for these patients.

26 Aug 2019

Enzyme induced by stress associated with liver cancer growth

An enzyme induced by stress to help reduce production of damaging free radicals is also used by liver cancer to regulate two major cell proliferation pathways that enable the cancer to thrive, scientists report.

22 Aug 2019

Liver dysfunction provokes cerebral molecular disturbances in two weeks

The liver plays a vital role as a filter in the human body. But what happens when it malfunctions? Researchers from the Universities of Geneva and Lausanne, the Vaud University Hospital Centre, the Centre for Biomedical Imaging, the Federal Polytechnic School of Lausanne and the University Hospitals of Geneva, Switzerland, teamed up to perform a detailed analysis of hepatic encephalopathy, a type of brain damage caused by chronic liver disease.

19 Aug 2019

Human apolipoprotein E promotes hepatitis B virus infection

Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published DATE in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University of Alabama at Birmingham School of Medicine.

From PLOS ONE 13 Aug 2019

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly half, study shows

A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.

10 Aug 2019

Pitt researchers first to grow genetically modified miniature human livers in the lab

Researchers at the University of Pittsburgh School of Medicine are the first to grow genetically modified miniature human livers in the laboratory, to emulate human liver disease progression and test therapeutics.

7 Aug 2019